Á lódáil...
The Neurokinin-1 Receptor Antagonist Aprepitant: An Intelligent Bullet against Cancer?
SIMPLE SUMMARY: Due to the lack of selectivity and the severe side-effects, cytostatics are the drugs of the present but not of the future and consequently new anticancer strategies must be developed. After binding to the neurokinin-1 receptor (NK-1R), NK-1R antagonists exert antitumor actions (anti...
Na minha lista:
| Foilsithe in: | Cancers (Basel) |
|---|---|
| Main Authors: | , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
MDPI
2020
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7564414/ https://ncbi.nlm.nih.gov/pubmed/32962202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12092682 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|